Showcasing Early Performance of Novel ADC DB-1317 & DUP9 Payload
- Introducing DualityBio ADC development and innovation in next-generation ADCs
- Spotlighting DUP9, a next-generation payload to increase ADC payload diversity
- Exploring design and early development of DB-1317, a novel ADC targeting GI cancer